Michael Seater

Mike joined Inscripta in July 2021 with a long record of successful tech sector financial management and reporting. A licensed CPA, Mike has successfully led four previous companies through the IPO filing process, including 10x Genomics in 2019. While at 10x Genomics, he was responsible for scaling the finance and accounting organization from pre-revenue to global manufacturing and sales operations. Mike brings a unique blend of controllership, budgeting, mergers and acquisitions, taxation and strategic finance experience having worked in environments ranging from early-stage private equity backed companies to Fortune 50 and Global 10 companies.